Results 31 to 40 of about 111,529 (192)

H.E.L.P. LDL-apheresis clinical experience in Italy

, 2011
H.E.L.P. LDL-apheresis clinical experience in ItalyStefanutti Claudia, Shafii Mahnaz, Di Giacomo Serafina, Morozzi Claudia, Mazzilli Sara and the Italian Multicenter Study on Low-Density-Lipoprotein -Apheresis Working GroupExtracorporeal Therapeutic ...
MOROZZI, CLAUDIA, STEFANUTTI, Claudia, M. Shafii, DI GIACOMO, SERAFINA, The Italian Multicenter Study O. N. Low Density Lipoprotein Apheresis Working Group, S. Mazzilli   +5 more
core   +1 more source

In vivo metabolism of LDL subfractions in patients with heterozygous FH on statin therapy

Journal of Lipid Research, 2004
LDL can be subfractionated into buoyant (1.020–1.029 g/ml−1), intermediate (1.030–1.040 g/ml−1), and dense (1.041–1.066 g/ml−1) LDLs. We studied the rebound of these LDL-subfractions after LDL apheresis in seven patients with heterozygous familial ...
H.C. Geiss, S. Bremer, P.H.R. Barrett, C. Otto, K.G. Parhofer   +4 more
doaj   +1 more source

Italian Multicenter Study on Low-Density Lipoprotein Apheresis Working Group 2009 Survey

, 2013
We present results of the second survey of the Italian Multicenter Study on Low-Density Lipoprotein Apheresis (IMSLDLa-WG/2). The study involved 18 centers in 2009, treating 66 males and 35 females, mean age 47 +/- 18 years.
MOROZZI, CLAUDIA, STEFANUTTI, Claudia, DI GIACOMO, SERAFINA, The Italian Multicenter Study O. N. Low Density Lipoprotein Apheresis Working Group   +3 more
core   +1 more source

LDL‐aférese no tratamento de hipercolesterolemia familiar: experiência do Hospital Santo António

Revista Portuguesa de Cardiologia, 2015
Resumo: Introdução: A hipercolesterolemia manifestada pelos níveis elevados de colesterol das lipoproteínas de baixa densidade constitui um fator de risco major para o desenvolvimento e progressão da doença aterosclerótica prematura.A adsorção direta de
Isabel Palma, Ana Rita Caldas, Isabel Mangas Palma, José Alexandre Queirós, Anselmo Madureira, José Carlos Oliveira, Paulo Palma, Carlos Correia, Maria Helena Ramos   +8 more
doaj   +1 more source

The High Price of Interrupted Follow-Up: Catastrophic Progression of Homozygous Familial Hypercholesterolemia-A Case Report and Literature Review. [PDF]

Clin Case Rep
ABSTRACT Familial hypercholesterolemia (FH) is the most common monogenic lipid disorder, primarily resulting from mutations in LDLR, APOB, and PCSK9 genes. These mutations cause persistently high levels of low‐density lipoprotein cholesterol (LDL‐C), predisposing affected individuals to premature atherosclerotic cardiovascular disease (ASCVD ...
Dastjerdi P, Aghababaei M, Nikfar R, Aghakouchakzadeh M, Mohseni-Badalabadi R, Hosseini K.   +5 more
europepmc   +2 more sources

Effects of LDL apheresis on blood rheology in two patients with homozygous familial hypercholesterolaemia

, 1997
Changes in haemorheological and lipid variables were investigated in 2 patients with homozygous familial hypercholesterolaemia (FH) treated with low-density lipoprotein (LDL) apheresis using dextran sulphate adsorbent.
Danielson, Bo G.,, Fadul, Jamal E.,, Sandhagen, Bo,, Linde, Torbjörn,, Wikström, Björn,, Vessby, Bengt,   +5 more
core   +8 more sources

Lipoprotein apheresis efficacy and challenges: single center experience

Hematology, Transfusion and Cell Therapy, 2022
Introduction: Lipoprotein apheresis (LA) is an extracorporeal therapy which removes apolipoprotein B-containing particles from the circulation. We evaluated techniques and efficiency of lipoprotein apheresis procedures applied to patients with familial ...
Zehra Narlı Özdemir, Uğur Şahin, Yasin Yıldırım, Cansın Tulunay Kaya, Osman İlhan   +4 more
doaj   +1 more source

Single Low-Density Lipoprotein Apheresis Does Not Improve Vascular Endothelial Function in Chronically Treated Hypercholesterolemic Patients

International Journal of Vascular Medicine, 2016
Objective. To investigate vascular endothelial function (VEF) responses to a single low-density lipoprotein (LDL) apheresis session in hypercholesterolemic patients undergoing chronic treatment. Methods. We measured brachial artery flow-mediated dilation
Kevin D. Ballard, Eunice Mah, Yi Guo, Richard S. Bruno, Beth A. Taylor, Jo Ellen Beam, Donna M. Polk, Paul D. Thompson   +7 more
doaj   +1 more source

Comparison of Different Ldl-Apheresis Techniques

, 1998
LDL-apheresis is an extracorporeal technique which removes all apo B100-containing lipoproteins (VLDL, LDL, Lp(a)) from plasma, in patients whith homozygous, and double heterozygous, familial hypercholesterolemia (FH).
C. Stefanutti, S. Di Giacomo, A. Vivenzio   +2 more
core   +1 more source

Long‐term prognosis of focal segmental glomerulosclerosis treated with therapeutic low‐density lipoprotein‐apheresis in patients with severe kidney dysfunction and proteinuria

Rheumatology & Autoimmunity, 2023
Background The prognosis of focal segmental glomerulosclerosis patients with nephrotic syndrome is estimated to be 10%–20% in 5 years and 30%–50% in 10 years, leading to end‐stage kidney disease.
Shinji Kitajima, Megumi Osima, Hisayuki Ogura, Shiori Nakagawa, Yuta Yamamura, Taito Miyake, Taro Miyagawa, Tadashi Toyama, Akinori Hara, Norihiko Sakai, Miho Shimizu, Takashi Wada, Yasunori Iwata   +12 more
doaj   +1 more source